In July 2023, Melanoma Focus received PIF TICK accreditation. The PIF TICK is the UK wide quality mark for trusted health information, achieving this official certification demonstrates our commitment to the provision of high-quality health information.
As well as producing accredited information explaining skin (cutaneous) melanomas, we create specific materials on rare melanomas and potential treatments as part of our wider work publishing NICE-accredited clinical guidelines for clinical teams.
The Melanoma TrialFinder was launched in 2022. Clinical trials are medical research studies involving patients, which allow the thorough testing of new treatments. We have created a resource where clinical trials are explained and you can search for potential UK trial options to discuss with the medical team.
From 2023, Melanoma Focus will be supporting Imogen Cheese, Founder of the Melanoma Patient Conference, a national patient conference by hosting and providing the organisation of this important event. This meeting provides a safe space for patients and carers to interact and network while hearing about the latest advances in melanoma medicine.